Journal of Alzheimer s Disease · 2014 · 14 citations · 23 references
MedicineNeurologyPsychiatryCognitive NeurologyDementiaMemoryAlzheimer DiseaseCognitive DeclineCognitive DisordersCognitive ImpairmentCognitive SymptomsMemory DisordersAmnestic ImpairmentCognitive Impairment EvaluationDisease Recognition FailureLongitudinal Cognitive DeclineMemory DysfunctionMild Cognitive Impairment ProgressionVerbal MemoryVisual Memory Impairment
We evaluate the longitudinal outcomes of amnestic mild cognitive impairment (aMCI) according to the modality of memory impairment involved. We recruited 788 aMCI patients and followed them up. aMCI patients were categorized into three groups according to the modality of memory impairment: Visual-aMCI, only visual memory impaired; Verbal-aMCI, only verbal memory impaired; and Both-aMCI, both visual and verbal memory impaired. Each aMCI group was further categorized according to the presence or absence of recognition failure. Risk of progression to dementia was compared with pooled logistic regression analyses while controlling for age, gender, education, and interval from baseline. Of the sample, 219 (27.8%) aMCI patients progressed to dementia. Compared to the Visual-aMCI group, Verbal-aMCI (OR = 1.98, 95% CI = 1.19-3.28, p = 0.009) and Both-aMCI (OR = 3.05, 95% CI = 1.97-4.71, p < 0.001) groups exhibited higher risks of progression to dementia. Memory recognition failure was associated with increased risk of progression to dementia only in the Visual-aMCI group, but not in the Verbal-aMCI and Both-aMCI groups. The Visual-aMCI without recognition failure group were subcategorized into aMCI with depression, small vessel disease, or accelerated aging, and these subgroups showed a variety of progression rates. Our findings underlined the importance of heterogeneous longitudinal outcomes of aMCI, especially Visual-aMCI, for designing and interpreting future treatment trials in aMCI.
23
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
Dynamics of Gray Matter Loss in Alzheimer's Disease
Paul M. Thompson, Kiralee M. Hayashi, Greig I. de Zubicaray et al. · Journal of Neuroscience · 2003 · 1.1K citations · Full text
Medicine, Neurology, Neuroscience +17
The neuropathology of probable Alzheimer disease and mild cognitive impairment
Julie A. Schneider, Zoe Arvanitakis, Sue E. Leurgans et al. · Annals of Neurology · 2009 · 931 citations · Full text
Medicine, Neurology, Neuroscience +17
In Vivo Mapping of Gray Matter Loss with Voxel-Based Morphometry in Mild Alzheimer's Disease
Jean‐Claude Baron, Gaël Chételat, Béatrice Desgranges et al. · NeuroImage · 2001 · 687 citations
Medicine, Neurology, Neuroscience +17